# Taysha Gene Therapies, Inc.: Form 8-K, filed Aug 29, 2023

- Company: [Taysha Gene Therapies, Inc.](/companies/tsha.md) (CIK 1806310)
- Form: 8-K
- Filed: 2023-08-29
- Accepted by EDGAR: Aug 29, 2023, 07:00 ET
- Period: 2023-08-28
- Accession: 0001193125-23-222964
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806310/000119312523222964/d521077d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806310/000119312523222964/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806310/000119312523222964/d521077d8k.htm

Filed Aug 29, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-222964. Last ingested by Listed: Oct 24, 2026, 14:57 ET. No prices; not investment advice.